Spotlight Asset Group, Inc. Novartis Ag Transaction History

Spotlight Asset Group, Inc.

$140 Million
Q2 2024

A detailed history of Spotlight Asset Group, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Spotlight Asset Group, Inc. holds 1,055 shares of NVS stock, worth $115,058. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,055

Previous 1,055 -0.0%

Holding current value

$115,058

Previous $102,000 9.8%

% of portfolio

0.08%

Previous 0.08%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$95.27 - $108.47 $5,144 - $5,857	54 Added 5.39%	1,055 $102,000
Q2 2023 Aug 09, 2023	BUY	$92.52 - $104.91 $92,612 - $105,014	1,001 New	1,001 $101,000
Q3 2022 Nov 18, 2022	SELL	$74.61 - $87.26 $244,347 - $285,776	-3,275 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$81.78 - $95.14 $31,894 - $37,104	-390 Reduced 10.64%	3,275 $268,000
Q2 2021 Aug 11, 2021	SELL	$85.24 - $94.15 $8,012 - $8,850	-94 Reduced 2.5%	3,665 $334,000
Q1 2021 Apr 07, 2021	SELL	$83.5 - $98.47 $108,299 - $127,715	-1,297 Reduced 25.65%	3,759 $321,000
Q4 2020 Feb 08, 2021	BUY	$78.07 - $94.43 $19,127 - $23,135	245 Added 5.09%	5,056 $477,000
Q3 2020 Oct 30, 2020	SELL	$82.14 - $91.0 $41,562 - $46,046	-506 Reduced 9.52%	4,811 $418,000
Q2 2020 Jul 23, 2020	SELL	$80.93 - $91.1 $23,307 - $26,236	-288 Reduced 5.14%	5,317 $464,000
Q1 2020 Apr 13, 2020	SELL	$70.67 - $99.01 $353 - $495	-5 Reduced 0.09%	5,605 $462,000
Q4 2019 Apr 13, 2020	BUY	$84.35 - $95.37 $473,203 - $535,025	5,610 New	5,610 $476,000

Others Institutions Holding NVS

# of Institutions

1,479

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $235B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spotlight Asset Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Spotlight Asset Group, Inc. with notifications on news.

Account

Spotlight Asset Group, Inc. Novartis Ag Transaction History